相关实验视频
Updated: Feb 20, 2026

04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
9.8K
低剂量德夫拉扎科特可减少手术后疼痛和炎症,主要是膝关节关节整形术后:随机对照试验
Dhanasekaran Soundarrajan1, Rithika Singh1, Shyju J S1
1Department of Orthopaedics, Ganga hospital, 313,Mettupalayam road, Coimbatore, India.
Journal of ISAKOS : joint disorders & orthopaedic sports medicine
|February 18, 2026
概括
在全膝关节整形术 (TKA) 后,低剂量口服除剂显示疼痛,功能和睡眠质量略有改善. 这种皮质类固醇表现出良好的安全性,表明它有可能作为TKA恢复的辅助疗法.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 手术后的疼痛,炎症和睡眠障碍是膝盖全关节整形术 (TKA) 后的重大挑战.
- 长期低剂量口服皮质类固醇治疗对TKA恢复的作用还不清楚.
- 这项研究调查了deflazacort在改善TKA结局方面的疗效和安全性.
研究的目的:
- 评估低剂量口服德夫拉扎科特在减少术后疼痛和改善初级TKA后睡眠质量的疗效.
- 评估TKA后延长低剂量除皮治疗的安全性.
- 为了比较Deflazacort和安慰剂组之间的功能恢复和炎症标志物.
主要方法:
- 一项前性,双盲,安慰剂对照试验,涉及100名接受初级TKA的患者.
- 患者在术后3周内接受口服德夫拉佐科特 (每天6毫克) 或安慰剂.
- 结果包括视觉模拟尺度 (VAS) 疼痛,匹兹堡睡眠质量指数 (PSQI),牛津膝盖得分 (OKS),炎症标志物和温度计.
主要成果:
- 德夫拉扎科特组在3个月后显示出统计学上显著的较低的VAS疼痛得分,并在3个月后改善睡眠质量 (PSQI).
- 在德夫拉扎科特组中,在1个月和3个月后,牛津膝关节评分 (OKS) 显著改善.
- 低炎症标志物 (ESR,CRP,IL-6) 和膝盖温度降低在德夫拉萨科特组中被注意到;没有报道任何不良事件.
结论:
- 在TKA后服用低剂量的口服除甲酸与疼痛,功能,睡眠和炎症的适度改善有关,具有出色的安全性.
- 虽然不超过临床重要差异的最小值,但deflazacort可能是TKA恢复的安全辅助疗法.
- 研究结果表明,在多式联络恢复方案中,德夫拉扎科特可能有助于减少阿片类药物使用并提高患者满意度.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
542
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
542
Peripheral Artery Disease V: Postoperative Nursing Management
431
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
431
Analgesia and Pain Management
2.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.1K
Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817

